EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes of conversion surgery for patients with locally advanced pancreatic cancer under strict indication criteria

Mihoko Yamada, Katsuhisa Ohgi, Ryo Ashida, Yoshiyasu Kato, Shimpei Otsuka, Hideyuki Dei, Katsuhiko Uesaka, Teiichi Sugiura

Surgery Today · 2026-07 · 56 (7) · 1320-1329

DOI: 10.1007/s00595-025-03223-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, online erschienen am 02.02.2026. Verfasst von Mihoko Yamada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimo-Nagakubo, Sunto-Nagaizumi, Shizuoka, 411-8777, Japan. mi.yamada@scc…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreatectomy, Conversion to Open Surgery. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nagoya University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Conversion surgery (CS) is performed for locally advanced pancreatic cancer (LAPC); however, the criteria for CS varies among institutions. This study aimed to evaluate the clinical outcomes of CS for LAPC based on strict indications at our center. METHODS: This study included patients diagnosed with and treated for LAPC between 2011 and 2021. The CS criteria indicated that the tumors shrunk to the same status as resectable pancreatic cancer (RPC) on imaging and were maintained for > 3 months. Additionally, tumors that had shrunk to a size corresponding to borderline resectable pancreatic cancer (BRPC) were observed on CT. RESULTS: Twenty-two patients underwent CS with a morbidity rate of 40.9% and no mortality. Overall survival after surgery in the LAPC group tended better than that in the BR and R groups (MST, LAPC, 59.7 months; BR, 38.6 months; R, 39.1 months; LAPC vs. BR, p = 0.085, vs. R, p = 0.065). Disease-free survival was similar across all resectability statuses: LAPC, 21.1 months; BR, 16.6 months; and R, 19.6 months (LAPC vs. BR, p = 1.000, vs. R, p = 1.000). CONCLUSION: CS in patients with LAPC under strict criteria showed promising outcomes, demonstrating the potential benefit of this approach in carefully selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPancreatectomyConversion to Open SurgeryHumansTreatment OutcomeFemaleMaleAgedSurvival RateMiddle AgedNeoplasm StagingDisease-Free Survival

Stichwörter der Autor:innen

Conversion surgeryLocally advanced pancreatic cancerPancreatic ductal adenocarcinoma

Autor:innen und Institutionen

  • Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimo-Nagakubo, Sunto-Nagaizumi, Shizuoka, 411-8777, Japan. mi.yamada@scchr.jp.
  • Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimo-Nagakubo, Sunto-Nagaizumi, Shizuoka, 411-8777, Japan.

Förderung

  • Nagoya University

Zitieren

APA

Yamada, M., Ohgi, K., Ashida, R., Kato, Y., Otsuka, S., Dei, H., Uesaka, K., & Sugiura, T. (2026). Outcomes of conversion surgery for patients with locally advanced pancreatic cancer under strict indication criteria. Surgery Today, 56(7), 1320-1329. https://doi.org/10.1007/s00595-025-03223-7

Vancouver

Yamada M, Ohgi K, Ashida R, Kato Y, Otsuka S, Dei H, et al. Outcomes of conversion surgery for patients with locally advanced pancreatic cancer under strict indication criteria. Surgery Today. 2026;56(7):1320-1329. doi:10.1007/s00595-025-03223-7

BibTeX
@article{Yamada2026,
  author = {Yamada, Mihoko and Ohgi, Katsuhisa and Ashida, Ryo and Kato, Yoshiyasu and Otsuka, Shimpei and Dei, Hideyuki and Uesaka, Katsuhiko and Sugiura, Teiichi},
  title = {Outcomes of conversion surgery for patients with locally advanced pancreatic cancer under strict indication criteria},
  journal = {Surgery Today},
  year = {2026},
  volume = {56},
  number = {7},
  pages = {1320--1329},
  doi = {10.1007/s00595-025-03223-7}
}
Kostenlos starten →